Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Repeated high-dose Xeomeen injections for lower-limb spasticity after brain lesions
2018-002499-42Phase 4Completed
- Sponsor
- Cliniques universitaires Saint-Luc
- Start
- Jul 2018
- Modality
- Recombinant Proteins and Enzymes
- Countries
- 1
01
Overview
Phase 4, open-label trial of botulinum toxin type A in Muscle spasm (2 arms), sponsored by Cliniques universitaires Saint-Luc. Primary endpoint: Functional functioning based on WHO International Classification of Functioning, Disability and Health. Started Jul 2018; status: completed.
02
Drugs
botulinum toxin type A
03
Conditions
Muscle spasm
Beyond the preview
Go deeper on 2018-002499-42.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2018-002499-42.